Research & Development Market Research Reports & Industry Analysis
Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize. The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.
Research & Development Industry Research & Market Reports
-
2022 Global Forecast for Cell Signaling (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid & Recombinant), End User (Pharma, Biotech, CRO) - Global Forecast to 2026
... is projected to reach USD 730 million by 2026 USD 515 million in 2021, at a CAGR of 7.2% during the forecast period. Growth in this market is driven by the increasing use of peptides ... Read More
-
Global Interferons Market Product Type (Interferon Alpha, Interferon Beta, Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma), Regional Forecasts 2021-2027
... XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period 2021-2027. The interferons are biopharmaceuticals made from live creatures like microbes and animal ... Read More
-
CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report By Target Antigen (CD19/CD22, BCMA, Others); By Indication (Diffuse Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Follicular Lymphoma (FL), Others); By Region: Segment Forecast, 2022 – 2029
... Lymphoma (FL), Others); By Region: Segment Forecast, 2022 – 2029 The global CAR-T cell therapy market size is expected to reach USD 20,566.5 million by 2029 according to a new study published by Polaris Market ... Read More
-
T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage ... Read More
-
Pharmaceutical Sterility Testing Market - By Type (In-House And Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, And Bacterial Endotoxin Testing), By Sample (Sterile Drugs, Medical Devices, And Biologics & Therapeutics), By End-Use (Compounding Pharmacies, Medical Devices Companies, And Pharmaceutical Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030
... Medical Devices Companies, And Pharmaceutical Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030 Market Overview Fatpos Global has released a report titled Pharmaceutical Sterility Testing Market - Analysis of ... Read More
-
PCSK9 Inhibitors (PCSK9i) disease - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 PCSK9 Inhibitors (PCSK9i) ... Read More
-
Interferon - Biosimilar Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Interferon Understanding ... Read More
-
Global Cell Therapy Manufacturing Market, By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies), By Source of Cell (Autologous v/s Allogenic), By Scale of Operation (Preclinical, Clinical, Commercial), By Source (In-House v/s Contract Manufacturing), By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), By Region, Competition Forecast and Opportunities, 2026
... v/s Contract Manufacturing), By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), By Region, Competition Forecast and Opportunities, 2026 Global cell therapy manufacturing market ... Read More
-
Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast - 2032
... the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan ... Read More
-
Cytokine Release Syndrome (CRS)-Epidemiology Forecast–2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Cytokine Release Syndrome ... Read More
-
The Market for Library Preparation and Target Enrichment for Next-Generation Sequencing (NGS) 2021
... including NGS sample preparation revenues and growth rates for 2021-2026 and NGS sample preparation revenues by geographic region for 2020 (North America, Europe, Asia-Pacific, rest-of-world). The introduction of smaller, cheaper benchtop NGS systems has expanded ... Read More
-
COVID-19 Testing Market Update 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends
... has been changed, perhaps permanently. Hundreds of test products are on the market to detect the virus, both for its presence and immune response. And billions of dollars have been added to the in vitro ... Read More
-
Rare Disease & Orphan Therapeutic Market Analysis & Forecast to 2025
... Cell Therapy (ACT) & IDO Inhibitors This industry analysis report tackles the major orphan drugs within the rare disease therapeutic market and encompasses the most prevalent and dominant therapies in this space. The market value ... Read More
-
Global Biosimulation - Market and Technology Forecast to 2028
... impairment to the human body. This feature of biosimulation is extensively used while designing drugs to cure illnesses. Biosimiluation helps quantify if a drug will be harmful to the human body with regards to toxicity ... Read More
-
Outsourcing in Drug Discovery, 9th Edition
... cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug discovery process, the business of contract drug discovery has ... Read More
-
Downstream Bioprocessing Markets (Chromatography Columns and Resins, Membrane Adsorbers, Filtration Systems, Sensors)
... plant tissue or fermentation broth. It is an essential step in producing pharmaceuticals, such as antibiotics, hormones (insulin and human growth hormone), antibodies, and vaccines. Downstream Bioprocessing Markets analyzes the current and potential world market ... Read More
-
Disruption in Healthcare: Amazon, Brexit, Trump, MACRA, Gig Workers, Aging - 27 Factors That Could Change the Business
... Status • Reimbursement Changes in Europe and Other Developed Nations • Brexit • Emerging Countries • Demographic Changes • Ransomware and Blockchain Strategies • Telemedicine • Walk-in Clinics • MACRA • Empowered Consumers • "Gig" ... Read More
-
Knowledge Centers Kalorama Information Pharmaceutical and Biotech
Research Assistance
